Prostate Cancer Screening: Transform Trial Launches to Help Men
Prostate cancer screening has emerged as a critical component in the early detection and management of one of the most common cancers affecting men in the UK.With the launch of the £42 million Transform trial, significant advancements are being made to improve prostate cancer diagnosis through innovative methods, including combining MRI scans with PSA tests.










